Title |
Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors |
|---|---|
Involved |
C. Massard (Verfasser)
R. Salazar (Verfasser) J. P. Armand (Verfasser) M. Majem (Verfasser)
Erwin Deutsch (Verfasser)
M. García (Verfasser) A. Oaknin (Verfasser) E. M. Fernández-García (Verfasser) A. Soto (Verfasser) J. C. Soria (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Investigational new drugs : an interdisciplinary journal for clinicians and scientists 30, 6, 4.1.2012, date:12.2012, Seite 2318-2326 |
Published |
2012 |
Language |
|
Country |
|
Topic |
|
Subject |
Pharmacology/Toxicology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2019062701261872692075 (URN) |
Record ID |
1189309386 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: